Back to BIIB

BIOGEN INC. Debt Repayment 2007-2025 | BIIB

Beta

What is debt repayment?

Debt repayment represents cash used to pay down outstanding bonds, loans, and other debt obligations as they mature.

What is BIOGEN INC.'s current debt repayment?

BIOGEN INC. (BIIB) annual debt repayment for 2025 was $1.75B, a 169.23% increase from 2024. BIOGEN INC. debt repayment for the quarter ending December 31, 2025 was $0.

What was BIOGEN INC.'s debt repayment in 2024?

BIOGEN INC. annual debt repayment for 2024 was $650.0M, a 19.74% decline from 2023.

What was BIOGEN INC.'s debt repayment in 2023?

BIOGEN INC. annual debt repayment for 2023 was $809.9M, a Infinity% increase from 2022.

What is BIOGEN INC.'s 5-year debt repayment CAGR?

BIOGEN INC. debt repayment grew at a compound annual growth rate (CAGR) of 3.13% from FY2020 to FY2025, going from $1.50B to $1.75B over 5 years.

Debt Repayment History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+3.1%
FY2020
$1.50B
FY2025
$1.75B
070809111213141516171819202122232425
5 years selected
Debt Repayment History
PeriodValueChangeSource
FY2025$1.75B+169.2%10-K
FY2024$650.0M-19.7%10-K
FY2023$809.9M-10-K
FY2022$0-10-K
FY2021$0-100.0%10-K
FY2020$1.50B-10-K
FY2019$0-100.0%10-K
FY2018$3.2M-99.4%10-K
FY2017$560.9M+20674.1%10-K
FY2016$2.7M+28.6%10-K
FY2015$2.1M-22.2%10-K
FY2014$2.7M-99.4%10-K
FY2013$452.4M+18532.6%10-K
FY2012$2.4M-78.8%10-K
FY2011$11.5M-10-K
FY2009$0-10-K
FY2008$0-100.0%10-K
FY2007$6.6M-10-K
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →